Cloned (Comment) | Organism |
---|---|
gene NAA10, genotyping, recombinant expression of His-MBP-tagged wild-type and mutant Naa10 in Escherichia coli and in HeLa cells | Homo sapiens |
Protein Variants | Comment | Organism |
---|---|---|
V111G | a naturally occuring 332 T > G missense mutant, the mutant Naa10 has a reduced stability and 85% reduced monomeric catalytic activity, while catalytic NatA function remains unaltered. NAA10-V111G has a reduced stability compared to wild-type NAA10, and in vitro acetylation assays reveal a reduced enzymatic activity of monomeric NAA10-V111G but not for NAA10-V111G in complex with NAA15 (NatA enzymatic activity). A glycine in position 111 instead of valine will not cause any steric clashes, but loss of the more bulky hydrophobic side chain of valine may possibly cause structural alterations affecting protein stability or acetyl-CoA binding | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | P41227 AND Q9BXJ9 | subunits Naa10 and Naa15 of NatA enzyme complex | - |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
HeLa cell | - |
Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
additional information | substrates are SESS24 or EEEI24. The ability of NAA10-V111G to acetylate the acidic N-termini EEEI24 is highly reduced compared to wild-type enzyme | Homo sapiens | ? | - |
- |
Synonyms | Comment | Organism |
---|---|---|
NAA10-NAA15 | - |
Homo sapiens |
NAA10-NAA15 protein complex | - |
Homo sapiens |
NatA | - |
Homo sapiens |
NatA protein complex | - |
Homo sapiens |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
acetyl-CoA | - |
Homo sapiens |
General Information | Comment | Organism |
---|---|---|
malfunction | NAA10 variants have been found in patients with an X-linked developmental disorder called Ogden syndrome in its most severe form and, in other familial or de novo cases, with variable degrees of syndromic intellectual disability (ID) affecting both sexes. The mutant NAA10-V111G has a reduced stability and 85% reduced monomeric catalytic activity, while catalytic NatA function remains unaltered. The syndromic cases may also require a degree of compromised NatA function. The Naa10-V111G phenotype shows mild/moderate non-syndromic intellectual disability, and delayed motor and language development, but normal behavior without autistic traits. The blood leukocyte X-inactivation pattern is within normal range (80/20) | Homo sapiens |
additional information | NatA homology modeling. Residue V111 is located towards the end of the beta5 strand, and a valine in this position is highly conserved in NAA10 homologues as well as in several other NAT catalytic subunits for which crystal structures have been solved. The side chain of V111 is forming a hydrophobic pocket together with Y145, M147, L119 and L109. It is also in close proximity to the sulfur group of acetyl-CoA, which seems to indicate a role for V111 in positioning of acetyl-CoA. A glycine in this position will not cause any steric clashes, but loss of the more bulky hydrophobic side chain of valine may possibly cause structural alterations affecting protein stability or AcCoA binding | Homo sapiens |
physiological function | the NAA10-NAA15 (NatA) protein complex is an N-terminal acetyltransferase responsible for acetylating about of eukaryotic proteins | Homo sapiens |